Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Stroke Cerebrovasc Dis ; 31(10): 106704, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36037677

ABSTRACT

OBJECTIVES: Falls can occur daily in stroke patients and appropriate independence assessments for fall prevention are required. Although previous studies evaluated the short physical performance battery (SPPB) in stroke patients, the relationship between SPPB and fall prediction and walking independence remains unclear. Therefore, we aimed to verify whether SPPB is a predictor of walking independence. MATERIALS AND METHODS: The present study included 105 hemiplegic stroke patients who were admitted to the rehabilitation ward and gave consent to participate. Cross-sectional physical function and functional independence measure cognitive (FIM-C) evaluation were conducted in hemiplegic stroke patients. Logistic regression analysis using the increasing variable method (likelihood ratio) was performed to extract factors for walking independence. Cutoff values were calculated for the extracted items using the receiver operating-characteristic (ROC) curve. RESULTS: Among 86 participants included in the final analysis, 36 were independent walkers and 50 were dependent walkers. In the logistic regression analysis, SPPB and FIM-C were extracted as factors for walking independence. The cutoff value was 7 [area under the curve (AUC), 0.94; sensitivity, 0.83; specificity, 0.73)] for SPPB and 32 (AUC, 0.83; sensitivity, 0.69; specificity, 0.57) for FIM-C in ROC analysis CONCLUSIONS: SPPB and FIM-C were extracted as factors for walking independence. Although SPPB alone cannot determine independent walking, combined assessment of SPPB with cognitive function may enable more accurate determination of walking independence.


Subject(s)
Stroke Rehabilitation , Stroke , Cross-Sectional Studies , Gait , Hemiplegia/diagnosis , Hemiplegia/etiology , Humans , Physical Functional Performance , Stroke/complications , Stroke/diagnosis
2.
Thanh-N. NGUYEN; Muhammad-M. QURESHI; Piers KLEIN; Hiroshi YAMAGAMI; Mohamad ABDALKADER; Robert MIKULIK; Anvitha SATHYA; Ossama-Yassin MANSOUR; Anna CZLONKOWSKA; Hannah LO; Thalia-S. FIELD; Andreas CHARIDIMOU; Soma BANERJEE; Shadi YAGHI; James-E. SIEGLER; Petra SEDOVA; Joseph KWAN; Diana-Aguiar DE-SOUSA; Jelle DEMEESTERE; Violiza INOA; Setareh-Salehi OMRAN; Liqun ZHANG; Patrik MICHEL; Davide STRAMBO; João-Pedro MARTO; Raul-G. NOGUEIRA; Espen-Saxhaug KRISTOFFERSEN; Georgios TSIVGOULIS; Virginia-Pujol LEREIS; Alice MA; Christian ENZINGER; Thomas GATTRINGER; Aminur RAHMAN; Thomas BONNET; Noémie LIGOT; Sylvie DE-RAEDT; Robin LEMMENS; Peter VANACKER; Fenne VANDERVORST; Adriana-Bastos CONFORTO; Raquel-C.T. HIDALGO; Daissy-Liliana MORA-CUERVO; Luciana DE-OLIVEIRA-NEVES; Isabelle LAMEIRINHAS-DA-SILVA; Rodrigo-Targa MARTÍNS; Letícia-C. REBELLO; Igor-Bessa SANTIAGO; Teodora SADELAROVA; Rosen KALPACHKI; Filip ALEXIEV; Elena-Adela CORA; Michael-E. KELLY; Lissa PEELING; Aleksandra PIKULA; Hui-Sheng CHEN; Yimin CHEN; Shuiquan YANG; Marina ROJE-BEDEKOVIC; Martin ČABAL; Dusan TENORA; Petr FIBRICH; Pavel DUŠEK; Helena HLAVÁČOVÁ; Emanuela HRABANOVSKA; Lubomír JURÁK; Jana KADLČÍKOVÁ; Igor KARPOWICZ; Lukáš KLEČKA; Martin KOVÁŘ; Jiří NEUMANN; Hana PALOUŠKOVÁ; Martin REISER; Vladimir ROHAN; Libor ŠIMŮNEK; Ondreij SKODA; Miroslav ŠKORŇA; Martin ŠRÁMEK; Nicolas DRENCK; Khalid SOBH; Emilie LESAINE; Candice SABBEN; Peggy REINER; Francois ROUANET; Daniel STRBIAN; Stefan BOSKAMP; Joshua MBROH; Simon NAGEL; Michael ROSENKRANZ; Sven POLI; Götz THOMALLA; Theodoros KARAPANAYIOTIDES; Ioanna KOUTROULOU; Odysseas KARGIOTIS; Lina PALAIODIMOU; José-Dominguo BARRIENTOS-GUERRA; Vikram HUDED; Shashank NAGENDRA; Chintan PRAJAPATI; P.N. SYLAJA; Achmad-Firdaus SANI; Abdoreza GHOREISHI; Mehdi FARHOUDI; Elyar SADEGHI-HOKMABADI; Mazyar HASHEMILAR; Sergiu-Ionut SABETAY; Fadi RAHAL; Maurizio ACAMPA; Alessandro ADAMI; Marco LONGONI; Raffaele ORNELLO; Leonardo RENIERI; Michele ROMOLI; Simona SACCO; Andrea SALMAGGI; Davide SANGALLI; Andrea ZINI; Kenichiro SAKAI; Hiroki FUKUDA; Kyohei FUJITA; Hirotoshi IMAMURA; Miyake KOSUKE; Manabu SAKAGUCHI; Kazutaka SONODA; Yuji MATSUMARU; Nobuyuki OHARA; Seigo SHINDO; Yohei TAKENOBU; Takeshi YOSHIMOTO; Kazunori TOYODA; Takeshi UWATOKO; Nobuyuki SAKAI; Nobuaki YAMAMOTO; Ryoo YAMAMOTO; Yukako YAZAWA; Yuri SUGIURA; Jang-Hyun BAEK; Si-Baek LEE; Kwon-Duk SEO; Sung-Il SOHN; Jin-Soo LEE; Anita-Ante ARSOVSKA; Chan-Yong CHIEH; Wan-Asyraf WAN-ZAIDI; Wan-Nur-Nafisah WAN-YAHYA; Fernando GONGORA-RIVERA; Manuel MARTINEZ-MARINO; Adrian INFANTE-VALENZUELA; Diederik DIPPEL; Dianne-H.K. VAN-DAM-NOLEN; Teddy-Y. WU; Martin PUNTER; Tajudeen-Temitayo ADEBAYO; Abiodun-H. BELLO; Taofiki-Ajao SUNMONU; Kolawole-Wasiu WAHAB; Antje SUNDSETH; Amal-M. AL-HASHMI; Saima AHMAD; Umair RASHID; Liliana RODRIGUEZ-KADOTA; Miguel-Ángel VENCES; Patrick-Matic YALUNG; Jon-Stewart-Hao DY; Waldemar BROLA; Aleksander DĘBIEC; Malgorzata DOROBEK; Michal-Adam KARLINSKI; Beata-M. LABUZ-ROSZAK; Anetta LASEK-BAL; Halina SIENKIEWICZ-JAROSZ; Jacek STASZEWSKI; Piotr SOBOLEWSKI; Marcin WIĄCEK; Justyna ZIELINSKA-TUREK; André-Pinho ARAÚJO; Mariana ROCHA; Pedro CASTRO; Patricia FERREIRA; Ana-Paiva NUNES; Luísa FONSECA; Teresa PINHO-E-MELO; Miguel RODRIGUES; M-Luis SILVA; Bogdan CIOPLEIAS; Adela DIMITRIADE; Cristian FALUP-PECURARIU; May-Adel HAMID; Narayanaswamy VENKETASUBRAMANIAN; Georgi KRASTEV; Jozef HARING; Oscar AYO-MARTIN; Francisco HERNANDEZ-FERNANDEZ; Jordi BLASCO; Alejandro RODRÍGUEZ-VÁZQUEZ; Antonio CRUZ-CULEBRAS; Francisco MONICHE; Joan MONTANER; Soledad PEREZ-SANCHEZ; María-Jesús GARCÍA-SÁNCHEZ; Marta GUILLÁN-RODRÍGUEZ; Gianmarco BERNAVA; Manuel BOLOGNESE; Emmanuel CARRERA; Anchalee CHUROJANA; Ozlem AYKAC; Atilla-Özcan ÖZDEMIR; Arsida BAJRAMI; Songul SENADIM; Syed-I. HUSSAIN; Seby JOHN; Kailash KRISHNAN; Robert LENTHALL; Kaiz-S. ASIF; Kristine BELOW; Jose BILLER; Michael CHEN; Alex CHEBL; Marco COLASURDO; Alexandra CZAP; Adam-H. DE-HAVENON; Sushrut DHARMADHIKARI; Clifford-J. ESKEY; Mudassir FAROOQUI; Steven-K. FESKE; Nitin GOYAL; Kasey-B. GRIMMETT; Amy-K. GUZIK; Diogo-C. HAUSSEN; Majesta HOVINGH; Dinesh JILLELA; Peter-T. KAN; Rakesh KHATRI; Naim-N. KHOURY; Nicole-L. KILEY; Murali-K. KOLIKONDA; Stephanie LARA; Grace LI; Italo LINFANTE; Aaron-I. LOOCHTAN; Carlos-D. LOPEZ; Sarah LYCAN; Shailesh-S. MALE; Fadi NAHAB; Laith MAALI; Hesham-E. MASOUD; Jiangyong MIN; Santiago ORGETA-GUTIERREZ; Ghada-A. MOHAMED; Mahmoud MOHAMMADEN; Krishna NALLEBALLE; Yazan RADAIDEH; Pankajavalli RAMAKRISHNAN; Bliss RAYO-TARANTO; Diana-M. ROJAS-SOTO; Sean RULAND; Alexis-N. SIMPKINS; Sunil-A. SHETH; Amy-K. STAROSCIAK; Nicholas-E. TARLOV; Robert-A. TAYLOR; Barbara VOETSCH; Linda ZHANG; Hai-Quang DUONG; Viet-Phuong DAO; Huynh-Vu LE; Thong-Nhu PHAM; Mai-Duy TON; Anh-Duc TRAN; Osama-O. ZAIDAT; Paolo MACHI; Elisabeth DIRREN; Claudio RODRÍGUEZ-FERNÁNDEZ; Jorge ESCARTÍN-LÓPEZ; Jose-Carlos FERNÁNDEZ-FERRO; Niloofar MOHAMMADZADEH; Neil-C. SURYADEVARA,-MD; Beatriz DE-LA-CRUZ-FERNÁNDEZ; Filipe BESSA; Nina JANCAR; Megan BRADY; Dawn SCOZZARI.
Journal of Stroke ; : 256-265, 2022.
Article in English | WPRIM (Western Pacific) | ID: wpr-938173

ABSTRACT

Background@#and Purpose Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. @*Methods@#We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). @*Results@#There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. @*Conclusions@#During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT.

3.
Intern Med ; 56(21): 2857-2863, 2017 Nov 01.
Article in English | MEDLINE | ID: mdl-28943539

ABSTRACT

Objective To assess the correlation between the angiographic appearance of cerebral collateral pathways or the degree of internal carotid artery stenosis (ICAS) and reduced cerebrovascular reactivity (CVR) estimated by single-photon emission computed tomography (SPECT) image analysis in patients with unilateral ICAS. Methods A retrospective analysis was performed in 42 patients with unilateral ICAS who underwent cerebral angiography and acetazolamide-challenged SPECT of the brain. Cerebral blood flow quantitation was performed using the quantitative SPECT/dual-table autoradiography method. The CVR in the middle cerebral artery (MCA) territory was evaluated using the stereotactic extraction estimation based on the Japanese extracranial-intracranial bypass trial (SEE-JET) program and classified as reduced (<18.4%) or non-reduced (≥18.4%). Angiographic collateralization was classified as circle of Willis (type 1), extracranial-intracranial (type 2), and leptomeningeal (type 3). The degree of ICAS was defined as severe (≥70% stenosis) or non-severe (<70%). Results Eight patients showed reduced CVR, including 6 (46%) of 13 with type 3 collaterals and 2 (7%) of 29 without type 3 collaterals (p=0.006). In contrast, type 1 and type 2 collaterals and severe ICAS were not significantly associated with reduced CVR. Conclusion In patients with unilateral ICAS, leptomeningeal collaterals are strongly correlated with reduced CVR in the MCA territory, which presumably increases the risk of cerebral hyperperfusion after carotid artery stenting (CAS). Therefore, these findings may be clinically applicable to the perioperative management of CAS.


Subject(s)
Brain/diagnostic imaging , Carotid Stenosis/diagnostic imaging , Middle Cerebral Artery/diagnostic imaging , Tomography, Emission-Computed, Single-Photon/methods , Acetazolamide/pharmacokinetics , Aged , Aged, 80 and over , Brain/pathology , Carotid Stenosis/pathology , Cerebral Angiography , Cerebrovascular Circulation/physiology , Constriction, Pathologic , Female , Humans , Imaging, Three-Dimensional , Male , Middle Aged , Middle Cerebral Artery/pathology , Retrospective Studies
4.
World Neurosurg ; 105: 529-533, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28619490

ABSTRACT

BACKGROUND: In endovascular embolization of intracranial aneurysms, a tortuous cervical internal carotid artery can limit guiding catheter access to a sufficiently high position. Although intermediate distal access catheters can go beyond the tortuous segment of internal carotid arteries, they may increase the risk of procedure-related complications, require significantly complex technical procedures, and limit the use of adjunctive techniques. Using simple neck extension alone, we successfully improved guiding catheter access in 2 patients. METHODS: Through a provocative test, we confirmed suitability of manual neck extension in 2 patients with severe posterior curvature of a tortuous internal carotid artery. Intraoperatively, we manually extended the neck and stretched the curvatures. We guided a 6F guiding catheter superiorly and performed coil embolization with an occlusion balloon catheter in 1 case and with the balloon-assisted neck remodeling technique in 1 case. RESULTS: Coil embolization was completed without any adverse events in both cases. CONCLUSIONS: The simple neck extension technique successfully improved accessibility of the guiding catheter. As the need for safe and highly skilled intervention increases, our technique may be useful because it can reduce procedure-related complications and allow balloon-assisted techniques.


Subject(s)
Carotid Artery, Internal/surgery , Catheterization/methods , Embolization, Therapeutic/methods , Endovascular Procedures/methods , Intracranial Aneurysm/surgery , Surgical Instruments/statistics & numerical data , Aged , Carotid Artery, Internal/diagnostic imaging , Catheterization/instrumentation , Embolization, Therapeutic/instrumentation , Endovascular Procedures/instrumentation , Female , Humans , Intracranial Aneurysm/diagnostic imaging , Middle Aged , Neck/diagnostic imaging , Neck/surgery
5.
J Stroke Cerebrovasc Dis ; 23(6): 1730-5, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24582791

ABSTRACT

Curative endovascular treatment of sphenoid wing dural arteriovenous fistula (dAVF) with pure cortical venous drainage is challenging because of its rarity, lack of accessible dural sinus for transvenous embolization (TVE), and proximity of skull base vital regions. Direct surgery to disconnect venous reflux has been favored. We report the curative endovascular treatment of two sphenoid wing dAVFs with pure cortical venous drainage. One patient revealed complete obliteration of dAVF by a single session of transarterial embolization (TAE). As part of strategic TAE for this complex dAVF, we used a novel approach to create a complete flow-arrest condition in which coils and an occlusion balloon were combined. A liquid agent was then injected across the pathological fistula and into the parent venous apparatus, thereby occluding the lesion. The other patient was treated with percutaneous TVE after TAE was unsuccessful. With a specific strategy and appropriate devices, the microcatheter was successfully introduced through sigmoid sinus, transverse sinus, superior sagittal sinus, and refluxing cortical vein by puncture of the jugular vein. Coils were deployed at the venous side of the fistula, resulting in successful obliteration of the dAVF. Sphenoid wing dAVF with pure cortical venous drainage could be curable by endovascular treatment with proper strategy and instruments when anatomical condition permits.


Subject(s)
Central Nervous System Vascular Malformations/surgery , Cranial Sinuses/surgery , Endovascular Procedures , Neurosurgical Procedures/methods , Adult , Humans , Male , Middle Aged , Treatment Outcome
6.
J Stroke Cerebrovasc Dis ; 22(7): 1107-10, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23017429

ABSTRACT

BACKGROUND: Delirium is considered to worsen life prognosis in elderly patients with stroke. We examined the effects of the melatonin receptor agonist ramelteon for treating delirium in elderly stroke patients with insomnia in comparison to the other drugs. METHODS: Elderly patients with delirium and insomnia after acute stroke who were treated with ramelteon (7 patients; mean age 76 years) and the other drugs (21 patients; mean age 77.3 years) between July 2011 and March 2012 at our hospital were retrospectively examined. RESULTS: All patients treated with ramelteon had a significant improvement within a week and were started on early and aggressive rehabilitation. No patient experienced oversedation, neurologic deterioration, or any other worsening effect associated with ramelteon treatment. CONCLUSIONS: Melatonin receptor agonists may be effective for the treatment of delirium in elderly patients with acute stroke.


Subject(s)
Delirium/drug therapy , Indenes/therapeutic use , Receptors, Melatonin/agonists , Stroke/complications , Aged , Aged, 80 and over , Delirium/complications , Female , Humans , Male , Middle Aged , Prognosis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...